Compass Minerals Intl (NYSE:CMP) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.29) by 10.34 percent. This is a 34.69 percent increase over losses of $(0.49) per share from the same period last year.
Related Posts
Planet Labs PBC Sees Q2 Revenue $53M-$55M Vs $60.17M Est.; FY24 Revenue $225M-$235M Vs $257.07M Est.
Financial Outlook
For the second quarter of fiscal year 2024, ending July 31, 2023, Planet expects revenue to be in the range of approximately $53 million to $55 million, representing
Taro Pharmaceutical Indus Earnings Preview
Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2023-10-26. Here’s what…
Molecular Instruments Announced The Patents Court Of England And Wales Has Ordered That Two Patents Owned By Advanced Cell Diagnostics, A Bio-Techne Company, Both Be Revoked, Advanced Cell Diagnostics’ Infringement Claims Against Molecular Instruments…
Molecular Instruments, Inc. announced that the Patents Court of the High Court of England and Wales has ordered: (1) that two patents owned by Advanced Cell Diagnostics, Inc. ((a Bio-Techne group company, NASDAQ:TECH)